Position in NBIX
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$630,845
+$125,623 QoQ
Shares Held
3,743
-2.4% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#445
of 773 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Summit Trail Advisors, LLC holds $30,486,390 across 11 Drug Manufacturers - Specialty & Generic names. NBIX ranks #7 (2.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HIMS |
Hims & Hers Health, Inc.
|
581,140 | $20,148,123 | |
| 2 | ELAN |
Elanco Animal Health Inc
|
108,576 | $2,672,055 | |
| 3 | ZTS |
Zoetis Inc.
|
31,739 | $2,280,764 | |
| 4 | PRGO |
PERRIGO Co plc
|
108,602 | $1,128,374 | |
| 5 | VTRS |
Viatris Inc
|
69,649 | $1,106,026 | |
| 6 | UTHR |
UNITED THERAPEUTICS Corp
|
1,537 | $832,792 | |
| 7 | NBIX |
Neurocrine Biosciences Inc
This page
|
3,743 | $630,845 | |
| 8 | TEVA |
Teva Pharmaceutical Industries Ltd
|
18,286 | $619,529 |
All Filings in NBIX
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $630,845 | 3,743 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $505,222 | 3,835 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $414,001 | 2,919 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $385,623 | 2,747 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $216,061 | 1,719 | Shares | Sole | 2025-08-14 | |
| No filing history on record for this holder in this stock. | ||||||